Canaccord Reiterates Buy on Edwards Lifesciences (EW); Sees Buying Opportunity
Tweet Send to a Friend
Canaccord Genuity analyst, Jason Mills, reiterated a Buy rating and $177.00 price target on Edwards Lifesciences (NYSE: EW) following a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
